Inventor
Mark de Boer
Inventor
Amersfoort, NL
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides21%
C12NMicroorganisms or enzymes16%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry6%
C10GCracking hydrocarbon oils6%
C07CAcyclic or carbocyclic compounds1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
7,820,807'Gene constructs coding for CD40-binding activating antibodies'20107,790,166'Anti-CD40 antibodies capable of blocking B-cell activation'20107,547,438'CD40-binding activating antibodies'20097,361,345'Anti-CD40 antibodies capable of blocking B-cell activation'20087,172,759'Induction of cytotoxic T lymphocyte responses using anti-CD40 antibodies'20076,899,879'Method for treating an IgE-mediated disease in a patient using anti-CD40 monoclonal antibodies'20056,893,553'Hydroprocessing catalyst and use thereof'20056,346,248'Methods of treating autoimmune diseases with a CD86-specific immunotoxin'20026,334,947'Catalyst comprising at least a hydrogenation metal component and a synthetic clay and a process of using'20026,315,998'Methods of blocking B-cell activation using anti-CD40 monoclonal antibodies'20016,127,299'Process for preparing a hydroprocessing catalyst from waste hydroprocessing catalyst'20006,071,519'Immunotoxins specific for CD86 expressing cells'20006,056,959'CD40 antigen antibody complex'20006,030,915'Process for preparing a large pore hydroprocessing catalyst'20006,004,552'Methods of blocking B cell proliferation using anti-CD40 monoclonal antibodies'19995,874,082'Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation'19995,869,050'Methods of blocking T-cell activation using anti-B7 monoclonal antibodies'19995,747,034'Methods and materials for the induction of T cell anergy'19985,677,165'Anti-CD40 monoclonal antibodies capable of blocking B-cell activation'19975,397,703'Method for generation of antibodies to cell surface molecules'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2005Patents assigned to CHIRON CORP (8)· patent assignee history
1998–2005Based in Beverwijk, NL· patent location history
1999–2002Based in Heemskerk, NL· patent location history
2000–2002Patents assigned to AKZO NOBEL NV (2)· patent assignee history
2000–2002Patents assigned to INNOGENETICS NV (2)· patent assignee history
2000–2005Based in Amersfoort, NL· patent location history
2000–2010Based in Beverwyk, NL· patent location history
2007–2010Patents assigned to PANGENETICS BV (3)· patent assignee history
2007–2010Based in Blaricum, NL· patent location history
2008–2010Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIRON CORP | 8 | 1997–2005 |
| PANGENETICS BV | 3 | 2007–2010 |
| AKZO NOBEL NV | 2 | 2000–2002 |
| INNOGENETICS NV | 2 | 2000–2002 |
| NOVARTIS VACCINES & DIAGNOSTIC | 2 | 2008–2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Amersfoort, NL | 4 | 2000–2005 |
| Beverwyk, NL | 3 | 2000–2010 |
| Heemskerk, NL | 3 | 1999–2002 |
| Blaricum, NL | 2 | 2007–2010 |
| Beverwijk, NL | 2 | 1998–2005 |